Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau Secretion: Good and Bad for Neurons
Camille Pernègre, Antoine Duquette, Nicole Leclerc
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
Morvane Colin, Simon Dujardin, Susanna Schraen‐Maschke, et al.
Acta Neuropathologica (2019) Vol. 139, Iss. 1, pp. 3-25
Open Access | Times Cited: 157
Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer’s disease and frontotemporal dementia
Sagar Gaikwad, Nicha Puangmalai, Alice Bittar, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109419-109419
Open Access | Times Cited: 150
Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies
Galina Limorenko, Hilal A. Lashuel
Chemical Society Reviews (2021) Vol. 51, Iss. 2, pp. 513-565
Open Access | Times Cited: 114
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges
Huiting Zheng, Huimin Sun, Qixu Cai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4969-4969
Open Access | Times Cited: 12
Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals
Sylvain Lehmann, Julien Dumurgier, Xavier Ayrignac, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 55
Astrocytic Propagation of Tau in the Context of Alzheimer's Disease
Rebecca M. Fleeman, Elizabeth A. Proctor
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 55
Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
Ben Boyarko, Vivian Hook
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 50
Cellular Conditions Responsible for Methylmercury-Mediated Neurotoxicity
Masatake Fujimura, Fusako Usuki
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7218-7218
Open Access | Times Cited: 32
The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer’s disease
Xiao‐Lan Liu, Meng Ye, Liang Ma
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 29
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Bartolo Tamburini, Giusto Davide Badami, Marco Pio La Manna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11922-11922
Open Access | Times Cited: 19
The Cell Biology of Tau Secretion
Maria Merezhko, Riikka‐Liisa Uronen, Henri J. Huttunen
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 46
Evolution, role in inflammation, and redox control of leaderless secretory proteins
Roberto Sitia, Anna Rubartelli
Journal of Biological Chemistry (2020) Vol. 295, Iss. 22, pp. 7799-7811
Open Access | Times Cited: 43
Role of the Lipid Membrane and Membrane Proteins in Tau Pathology
Eugene Bok, Eunju Leem, Boram Lee, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 38
Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis
Heather M. Terron, Sagar J. Parikh, Samer O. Abdul‐Hay, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies
Narendran Annadurai, Juan Bautista De Sanctis, Marián Hajdúch, et al.
Experimental Neurology (2021) Vol. 343, pp. 113756-113756
Closed Access | Times Cited: 31
Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies
Élodie Leroux, Romain Perbet, Raphaëlle Caillierez, et al.
Molecular Therapy (2021) Vol. 30, Iss. 2, pp. 782-797
Open Access | Times Cited: 28
Delivery of Intravenously Administered Antibodies Targeting Alzheimer’s Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis
Toshihiko Tashima
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 411-411
Open Access | Times Cited: 21
Dysfunctional microglia and tau pathology in Alzheimer’s disease
Gunel Ayyubova
Reviews in the Neurosciences (2022) Vol. 34, Iss. 4, pp. 443-458
Closed Access | Times Cited: 20
Lung endothelium, tau, and amyloids in health and disease
Ron Balczon, Mike T. Lin, S.B. Voth, et al.
Physiological Reviews (2023) Vol. 104, Iss. 2, pp. 533-587
Open Access | Times Cited: 12
Recent Insights on Glutamatergic Dysfunction in Alzheimer’s Disease and Therapeutic Implications
Priyanka D. Pinky, Jeremiah C. Pfitzer, Jared I. Senfeld, et al.
The Neuroscientist (2022) Vol. 29, Iss. 4, pp. 461-471
Closed Access | Times Cited: 18
Cross-seeding by prion protein inactivates TDP-43
Stella A. Polido, Cristiana Stuani, Aaron Voigt, et al.
Brain (2023) Vol. 147, Iss. 1, pp. 240-254
Closed Access | Times Cited: 10
Similarities and Differences in the Pattern of Tau Hyperphosphorylation in Physiological and Pathological Conditions: Impacts on the Elaboration of Therapies to Prevent Tau Pathology
Antoine Duquette, Camille Pernègre, Ariane Veilleux Carpentier, et al.
Frontiers in Neurology (2021) Vol. 11
Open Access | Times Cited: 23
Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly
Erin E. Congdon, Yixiang Jiang, Einar M. Sigurdsson
Seminars in Cell and Developmental Biology (2021) Vol. 126, pp. 125-137
Open Access | Times Cited: 21
Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies
Jie Yang, Naiting Shen, Jianying Shen, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 7, pp. 4712-4731
Open Access | Times Cited: 9
Distinct Neurotoxic Effects of Extracellular Tau Species in Primary Neuronal-Glial Cultures
Katryna Pampuščenko, Ramunė Morkūnienė, Lukas Krasauskas, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 2, pp. 658-667
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top